Study authors proposed bariatric surgery serve as a first-line treatment for clinical obesity, but as a second-line risk-reduction option for preclinical obesity as pharmacotherapy expands.

Supports optimization of metabolic function through nutrition, monitoring, and lifestyle guidance.

Supports users in reaching and maintaining a healthy body weight through behavioral and nutritional tools.